Results 231 to 240 of about 131,813 (277)
Some of the next articles are maybe not open access.
1999
At this writing, inactivated vaccines that offer a safe, convenient, and durably efficacious alternative to the use of immune globulin (IG) are available as pre-exposure prophylaxis against hepatitis A virus (HAV) for both pediatric and adult populations.
openaire +1 more source
At this writing, inactivated vaccines that offer a safe, convenient, and durably efficacious alternative to the use of immune globulin (IG) are available as pre-exposure prophylaxis against hepatitis A virus (HAV) for both pediatric and adult populations.
openaire +1 more source
2016
As countries prosper, anti-HAV seroprevalance decreases; that is why infection is more commonly encountered in advanced age cases in developed countries. The presence of the risk of developing fulminant hepatitis and the increase in touristic travels to endemic areas, emphasizes the importance of active immunization.
KOCAKAYA, Ozan, AVŞAR, Erol
openaire +1 more source
As countries prosper, anti-HAV seroprevalance decreases; that is why infection is more commonly encountered in advanced age cases in developed countries. The presence of the risk of developing fulminant hepatitis and the increase in touristic travels to endemic areas, emphasizes the importance of active immunization.
KOCAKAYA, Ozan, AVŞAR, Erol
openaire +1 more source
Hepatitis A vaccine inactivated/hepatitis B vaccine recombinant
Reactions Weekly, 1997openaire +1 more source
The oncologic burden of hepatitis C virus infection: A clinical perspective
Ca-A Cancer Journal for Clinicians, 2017Harrys A Torres +2 more
exaly
Hepatitis A vaccine inactivated/hepatitis B vaccine recombinant
Reactions Weekly, 2005openaire +1 more source